Evidence map›Paper›PMID 37693158›Full record

ReviewAmerican journal of cancer research2023

Role of the RNA-binding protein family in gynecologic cancers.

Linlin Hao, Jian Zhang, Zhongshan Liu, Zhiliang Zhang, Tiezhu Mao, Jie Guo

Open access · greenAbstract readReview
In one paragraph

Review in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Linlin HaoDepartment of Tumor Radiotherapy, The Second Hospital of Jilin University Changchun 130041, Jilin, China.
Jian ZhangSchool of Life Sciences, Department of Biology, Southern University of Science and Technology Shenzhen 518055, Guangdong, China.
Zhongshan LiuDepartment of Tumor Radiotherapy, The Second Hospital of Jilin University Changchun 130041, Jilin, China.
Zhiliang ZhangDepartment of Tumor Radiotherapy, The Second Hospital of Jilin University Changchun 130041, Jilin, China.
Tiezhu MaoDepartment of Tumor Radiotherapy, The Second Hospital of Jilin University Changchun 130041, Jilin, China.
Jie GuoDepartment of Tumor Radiotherapy, The Second Hospital of Jilin University Changchun 130041, Jilin, China.
Jilin Province Tumor Hospital · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gynecological cancers pose a threat to women's health. Although early-stage gynecological cancers show good outcomes after standardized treatment, the prognosis of patients with advanced, met-astatic, and recurrent cancers is poor. RNA-binding proteins (RBPs) are important cellular proteins that interact with RNA through RNA-binding domains and participate extensively in post-transcriptional regulatory processes, such as mRNA alternative splicing, polyadenylation, intracellular localization and stability, and translation. Abnormal RBP expression affects the normal function of oncogenes and tumor suppressor genes in many malignancies, thus leading to the occurrence or progression of cancers. Similarly, RBPs play crucial roles in gynecological carcinogenesis. We summarize the role of RBPs in gynecological malignancies and explore their potential in the diagnosis and treatment of cancers. The findings summarized in this review may provide a guide for future research on the functions of RBPs.

Indexed as

cervical cancerendometrial cancerGynecological cancerovarian cancerRNA-binding protein

Identifiers

PMID37693158
PMCPMC10492115
OpenAlexW4386591764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.